Global Stem Cell Therapy Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global stem cell therapy market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global stem cell therapy market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Cancer - Market size and forecast 2022-2027
Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
6.4 Musculoskeletal disorder - Market size and forecast 2022-2027
Exhibit 38: Chart on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
6.5 Cardiovascular disease - Market size and forecast 2022-2027
Exhibit 42: Chart on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ million)
Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 52: Chart on Type - Market share 2022-2027 (%)
Exhibit 53: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 54: Chart on Comparison by Type
Exhibit 55: Data Table on Comparison by Type
7.3 Allogeneic transplants - Market size and forecast 2022-2027
Exhibit 56: Chart on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
7.4 Autologous transplants - Market size and forecast 2022-2027
Exhibit 60: Chart on Autologous transplants - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Autologous transplants - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Autologous transplants - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Autologous transplants - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Athersys Inc.
Exhibit 115: Athersys Inc. - Overview
Exhibit 116: Athersys Inc. - Product/Service
Exhibit 117: Athersys Inc. - Key offerings
12.4 Bristol Myers Squibb Co.
Exhibit 118: Bristol Myers Squibb Co. - Overview
Exhibit 119: Bristol Myers Squibb Co. - Product/Service
Exhibit 120: Bristol Myers Squibb Co. - Key news
Exhibit 121: Bristol Myers Squibb Co. - Key offerings
12.5 CRISPR Therapeutics AG
Exhibit 122: CRISPR Therapeutics AG - Overview
Exhibit 123: CRISPR Therapeutics AG - Product/Service
Exhibit 124: CRISPR Therapeutics AG - Key offerings
12.6 Cynata Therapeutics Ltd.
Exhibit 125: Cynata Therapeutics Ltd. - Overview
Exhibit 126: Cynata Therapeutics Ltd. - Product/Service
Exhibit 127: Cynata Therapeutics Ltd. - Key offerings
12.7 FUJIFILM Corp.
Exhibit 128: FUJIFILM Corp. - Overview
Exhibit 129: FUJIFILM Corp. - Business segments
Exhibit 130: FUJIFILM Corp. - Key news
Exhibit 131: FUJIFILM Corp. - Key offerings
Exhibit 132: FUJIFILM Corp. - Segment focus
12.8 Gamida Cell Ltd.
Exhibit 133: Gamida Cell Ltd. - Overview
Exhibit 134: Gamida Cell Ltd. - Product/Service
Exhibit 135: Gamida Cell Ltd. - Key offerings
12.9 Johnson and Johnson
Exhibit 136: Johnson and Johnson - Overview
Exhibit 137: Johnson and Johnson - Business segments
Exhibit 138: Johnson and Johnson - Key news
Exhibit 139: Johnson and Johnson - Key offerings
Exhibit 140: Johnson and Johnson - Segment focus
12.10 Lonza Group Ltd.
Exhibit 141: Lonza Group Ltd. - Overview
Exhibit 142: Lonza Group Ltd. - Business segments
Exhibit 143: Lonza Group Ltd. - Key news
Exhibit 144: Lonza Group Ltd. - Key offerings
Exhibit 145: Lonza Group Ltd. - Segment focus
12.11 Mesoblast Ltd.
Exhibit 146: Mesoblast Ltd. - Overview
Exhibit 147: Mesoblast Ltd. - Product/Service
Exhibit 148: Mesoblast Ltd. - Key offerings
12.12 Novartis AG
Exhibit 149: Novartis AG - Overview
Exhibit 150: Novartis AG - Business segments
Exhibit 151: Novartis AG - Key offerings
Exhibit 152: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 153: Pfizer Inc. - Overview
Exhibit 154: Pfizer Inc. - Product/Service
Exhibit 155: Pfizer Inc. - Key news
Exhibit 156: Pfizer Inc. - Key offerings
12.14 Pluristem Therapeutics Inc.
Exhibit 157: Pluristem Therapeutics Inc. - Overview
Exhibit 158: Pluristem Therapeutics Inc. - Product/Service
Exhibit 159: Pluristem Therapeutics Inc. - Key offerings
12.15 ReNeuron Group plc
Exhibit 160: ReNeuron Group plc - Overview
Exhibit 161: ReNeuron Group plc - Product/Service
Exhibit 162: ReNeuron Group plc - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 164: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Vericel Corp.
Exhibit 167: Vericel Corp. - Overview
Exhibit 168: Vericel Corp. - Product/Service
Exhibit 169: Vericel Corp. - Key news
Exhibit 170: Vericel Corp. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global stem cell therapy market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 50: Market opportunity by Application ($ million)
Exhibits 51: Data Table on Market opportunity by Application ($ million)
Exhibits 52: Chart on Type - Market share 2022-2027 (%)
Exhibits 53: Data Table on Type - Market share 2022-2027 (%)
Exhibits 54: Chart on Comparison by Type
Exhibits 55: Data Table on Comparison by Type
Exhibits 56: Chart on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Autologous transplants - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Autologous transplants - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Autologous transplants - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Autologous transplants - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Type ($ million)
Exhibits 65: Data Table on Market opportunity by Type ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share by geography 2022-2027 (%)
Exhibits 68: Data Table on Market share by geography 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity by geography ($ million)
Exhibits 108: Data Tables on Market opportunity by geography ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Athersys Inc. - Overview
Exhibits 116: Athersys Inc. - Product/Service
Exhibits 117: Athersys Inc. - Key offerings
Exhibits 118: Bristol Myers Squibb Co. - Overview
Exhibits 119: Bristol Myers Squibb Co. - Product/Service
Exhibits 120: Bristol Myers Squibb Co. - Key news
Exhibits 121: Bristol Myers Squibb Co. - Key offerings
Exhibits 122: CRISPR Therapeutics AG - Overview
Exhibits 123: CRISPR Therapeutics AG - Product/Service
Exhibits 124: CRISPR Therapeutics AG - Key offerings
Exhibits 125: Cynata Therapeutics Ltd. - Overview
Exhibits 126: Cynata Therapeutics Ltd. - Product/Service
Exhibits 127: Cynata Therapeutics Ltd. - Key offerings
Exhibits 128: FUJIFILM Corp. - Overview
Exhibits 129: FUJIFILM Corp. - Business segments
Exhibits 130: FUJIFILM Corp. - Key news
Exhibits 131: FUJIFILM Corp. - Key offerings
Exhibits 132: FUJIFILM Corp. - Segment focus
Exhibits 133: Gamida Cell Ltd. - Overview
Exhibits 134: Gamida Cell Ltd. - Product/Service
Exhibits 135: Gamida Cell Ltd. - Key offerings
Exhibits 136: Johnson and Johnson - Overview
Exhibits 137: Johnson and Johnson - Business segments
Exhibits 138: Johnson and Johnson - Key news
Exhibits 139: Johnson and Johnson - Key offerings
Exhibits 140: Johnson and Johnson - Segment focus
Exhibits 141: Lonza Group Ltd. - Overview
Exhibits 142: Lonza Group Ltd. - Business segments
Exhibits 143: Lonza Group Ltd. - Key news
Exhibits 144: Lonza Group Ltd. - Key offerings
Exhibits 145: Lonza Group Ltd. - Segment focus
Exhibits 146: Mesoblast Ltd. - Overview
Exhibits 147: Mesoblast Ltd. - Product/Service
Exhibits 148: Mesoblast Ltd. - Key offerings
Exhibits 149: Novartis AG - Overview
Exhibits 150: Novartis AG - Business segments
Exhibits 151: Novartis AG - Key offerings
Exhibits 152: Novartis AG - Segment focus
Exhibits 153: Pfizer Inc. - Overview
Exhibits 154: Pfizer Inc. - Product/Service
Exhibits 155: Pfizer Inc. - Key news
Exhibits 156: Pfizer Inc. - Key offerings
Exhibits 157: Pluristem Therapeutics Inc. - Overview
Exhibits 158: Pluristem Therapeutics Inc. - Product/Service
Exhibits 159: Pluristem Therapeutics Inc. - Key offerings
Exhibits 160: ReNeuron Group plc - Overview
Exhibits 161: ReNeuron Group plc - Product/Service
Exhibits 162: ReNeuron Group plc - Key offerings
Exhibits 163: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 164: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibits 165: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 166: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 167: Vericel Corp. - Overview
Exhibits 168: Vericel Corp. - Product/Service
Exhibits 169: Vericel Corp. - Key news
Exhibits 170: Vericel Corp. - Key offerings
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global stem cell therapy market: Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson, Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluristem Therapeutics Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rise in costs of stem cell transplantation.'

According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Athersys Inc.
• Becton Dickinson and Co.
• Brainstorm Cell Therapeutics Inc.
• Bristol Myers Squibb Co.
• CRISPR Therapeutics AG
• Cynata Therapeutics Ltd.
• Cytori Therapeutics Inc.
• FUJIFILM Corp.
• Gamida Cell Ltd.
• Johnson and Johnson
• Lonza Group Ltd.
• Mesoblast Ltd.
• Novartis AG
• Pfizer Inc.
• Pluristem Therapeutics Inc.
• ReNeuron Group plc
• STEMCELL Technologies Inc.
• Takeda Pharmaceutical Co. Ltd.
• Thermo Fisher Scientific Inc.
• Vericel Corp.